vs
Side-by-side financial comparison of Citius Pharmaceuticals, Inc. (CTXR) and KOSS CORP (KOSS). Click either name above to swap in a different company.
Citius Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.9M, roughly 1.4× KOSS CORP). KOSS CORP runs the higher net margin — -19.8% vs -238.2%, a 218.4% gap on every dollar of revenue.
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing innovative prescription therapies addressing unmet medical needs across critical care, oncology, anti-infective treatment, and supportive care segments, primarily serving the U.S. healthcare market.
Koss Corporation is a company in Milwaukee, Wisconsin, US that manufactures headphones. The company created the first high-fidelity stereo headphones in 1958.
CTXR vs KOSS — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $2.9M |
| Net Profit | $-9.4M | $-565.4K |
| Gross Margin | 80.0% | 29.0% |
| Operating Margin | -228.7% | -35.5% |
| Net Margin | -238.2% | -19.8% |
| Revenue YoY | — | -19.6% |
| Net Profit YoY | 8.6% | -700.6% |
| EPS (diluted) | $-0.38 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9M | $2.9M | ||
| Q3 25 | — | $4.1M | ||
| Q2 25 | — | $3.1M | ||
| Q1 25 | — | $2.8M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $3.2M | ||
| Q2 24 | — | $2.9M | ||
| Q1 24 | — | $2.6M |
| Q4 25 | $-9.4M | $-565.4K | ||
| Q3 25 | — | $243.7K | ||
| Q2 25 | — | $-232.7K | ||
| Q1 25 | — | $-316.7K | ||
| Q4 24 | — | $94.1K | ||
| Q3 24 | — | $-419.5K | ||
| Q2 24 | — | $-110.4K | ||
| Q1 24 | — | $-313.8K |
| Q4 25 | 80.0% | 29.0% | ||
| Q3 25 | — | 40.0% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 39.0% | ||
| Q4 24 | — | 39.5% | ||
| Q3 24 | — | 36.6% | ||
| Q2 24 | — | 40.4% | ||
| Q1 24 | — | 31.9% |
| Q4 25 | -228.7% | -35.5% | ||
| Q3 25 | — | -1.1% | ||
| Q2 25 | — | -14.2% | ||
| Q1 25 | — | -18.7% | ||
| Q4 24 | — | -4.0% | ||
| Q3 24 | — | -19.9% | ||
| Q2 24 | — | -11.0% | ||
| Q1 24 | — | -23.1% |
| Q4 25 | -238.2% | -19.8% | ||
| Q3 25 | — | 6.0% | ||
| Q2 25 | — | -7.5% | ||
| Q1 25 | — | -11.4% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | -13.1% | ||
| Q2 24 | — | -3.8% | ||
| Q1 24 | — | -11.9% |
| Q4 25 | $-0.38 | $-0.06 | ||
| Q3 25 | — | $0.03 | ||
| Q2 25 | — | $-0.02 | ||
| Q1 25 | — | $-0.03 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | — | $-0.05 | ||
| Q2 24 | — | $-0.01 | ||
| Q1 24 | — | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.7M | $15.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $80.0M | $30.3M |
| Total Assets | $140.4M | $36.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.7M | $15.5M | ||
| Q3 25 | — | $16.5M | ||
| Q2 25 | — | $15.7M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $9.7M | ||
| Q3 24 | — | $11.9M | ||
| Q2 24 | — | $14.9M | ||
| Q1 24 | — | $9.9M |
| Q4 25 | $80.0M | $30.3M | ||
| Q3 25 | — | $30.9M | ||
| Q2 25 | — | $30.6M | ||
| Q1 25 | — | $30.7M | ||
| Q4 24 | — | $31.0M | ||
| Q3 24 | — | $30.8M | ||
| Q2 24 | — | $31.1M | ||
| Q1 24 | — | $31.1M |
| Q4 25 | $140.4M | $36.8M | ||
| Q3 25 | — | $37.7M | ||
| Q2 25 | — | $37.2M | ||
| Q1 25 | — | $37.3M | ||
| Q4 24 | — | $37.4M | ||
| Q3 24 | — | $38.1M | ||
| Q2 24 | — | $37.2M | ||
| Q1 24 | — | $37.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.0M | $-760.8K |
| Free Cash FlowOCF − Capex | — | $-1.1M |
| FCF MarginFCF / Revenue | — | -37.5% |
| Capex IntensityCapex / Revenue | — | 10.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-546.7K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-13.0M | $-760.8K | ||
| Q3 25 | — | $762.6K | ||
| Q2 25 | — | $-534.9K | ||
| Q1 25 | — | $370.4K | ||
| Q4 24 | — | $-252.0K | ||
| Q3 24 | — | $201.6K | ||
| Q2 24 | — | $-174.0K | ||
| Q1 24 | — | $328.6K |
| Q4 25 | — | $-1.1M | ||
| Q3 25 | — | $761.5K | ||
| Q2 25 | — | $-541.8K | ||
| Q1 25 | — | $306.2K | ||
| Q4 24 | — | $-314.3K | ||
| Q3 24 | — | $-155.6K | ||
| Q2 24 | — | $-174.8K | ||
| Q1 24 | — | $269.3K |
| Q4 25 | — | -37.5% | ||
| Q3 25 | — | 18.7% | ||
| Q2 25 | — | -17.6% | ||
| Q1 25 | — | 11.0% | ||
| Q4 24 | — | -8.8% | ||
| Q3 24 | — | -4.9% | ||
| Q2 24 | — | -6.0% | ||
| Q1 24 | — | 10.2% |
| Q4 25 | — | 10.9% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 2.3% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 2.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.13× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -2.68× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
